Brokerages Anticipate Ventas, Inc. (NYSE:VTR) Will Announce Quarterly Sales of $912.22 Million

Brokerages expect that Ventas, Inc. (NYSE:VTR) will report sales of $912.22 million for the current fiscal quarter, according to Zacks. Four analysts have made estimates for Ventas’ earnings, with the lowest sales estimate coming in at $888.30 million and the highest estimate coming in at $923.00 million. Ventas posted sales of $943.20 million in the same quarter last year, which suggests a negative year-over-year growth rate of 3.3%. The company is scheduled to announce its next quarterly earnings results on Friday, August 6th.

According to Zacks, analysts expect that Ventas will report full year sales of $3.65 billion for the current year, with estimates ranging from $3.57 billion to $3.72 billion. For the next year, analysts anticipate that the firm will post sales of $3.80 billion, with estimates ranging from $3.64 billion to $3.95 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that cover Ventas.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Friday, May 7th. The real estate investment trust reported ($0.15) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.70 by ($0.85). Ventas had a return on equity of 3.88% and a net margin of 10.49%. The company had revenue of $910.29 million for the quarter, compared to analyst estimates of $896.37 million. During the same quarter in the prior year, the firm earned $0.97 earnings per share. The company’s revenue for the quarter was down 10.1% on a year-over-year basis.

VTR has been the subject of several research reports. Wells Fargo & Company lifted their price objective on Ventas from $40.00 to $50.00 in a research report on Thursday, March 11th. KeyCorp raised shares of Ventas from an “underweight” rating to an “overweight” rating and lifted their target price for the stock from $49.00 to $60.00 in a research note on Thursday. Royal Bank of Canada lifted their target price on shares of Ventas from $54.00 to $58.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 2nd. Morgan Stanley lifted their target price on shares of Ventas from $52.00 to $58.00 and gave the stock an “equal weight” rating in a research note on Monday, March 22nd. Finally, Robert W. Baird raised shares of Ventas from a “neutral” rating to an “outperform” rating and set a $58.00 target price for the company in a research note on Thursday. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the stock. Ventas currently has a consensus rating of “Hold” and an average price target of $49.72.

Shares of Ventas stock traded down $0.32 during trading on Friday, hitting $54.32. 65,700 shares of the company were exchanged, compared to its average volume of 2,181,382. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 1.20. Ventas has a fifty-two week low of $26.87 and a fifty-two week high of $58.10. The stock has a market capitalization of $20.38 billion, a price-to-earnings ratio of 49.79, a P/E/G ratio of 4.34 and a beta of 1.06. The firm has a 50 day moving average price of $54.76 and a 200 day moving average price of $50.66.

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 14th. Shareholders of record on Thursday, April 1st were paid a $0.45 dividend. The ex-dividend date of this dividend was Wednesday, March 31st. This represents a $1.80 dividend on an annualized basis and a yield of 3.31%. Ventas’s dividend payout ratio is 46.75%.

In other news, CEO Debra A. Cafaro sold 18,076 shares of the company’s stock in a transaction that occurred on Thursday, April 1st. The stock was sold at an average price of $53.33, for a total value of $963,993.08. Following the completion of the transaction, the chief executive officer now directly owns 759,352 shares of the company’s stock, valued at $40,496,242.16. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Robert F. Probst sold 5,200 shares of the stock in a transaction on Monday, February 22nd. The stock was sold at an average price of $54.00, for a total value of $280,800.00. Following the sale, the chief financial officer now owns 142,591 shares in the company, valued at approximately $7,699,914. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 59,086 shares of company stock valued at $3,229,264. Insiders own 1.16% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in Ventas in the 4th quarter worth $25,000. Orion Capital Management LLC acquired a new stake in Ventas during the fourth quarter valued at $25,000. GPS Wealth Strategies Group LLC acquired a new stake in shares of Ventas in the first quarter valued at about $26,000. MUFG Americas Holdings Corp grew its position in shares of Ventas by 474.7% in the first quarter. MUFG Americas Holdings Corp now owns 500 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 413 shares during the period. Finally, Inspire Advisors LLC purchased a new position in shares of Ventas in the fourth quarter worth about $25,000. Institutional investors own 90.54% of the company’s stock.

Ventas Company Profile

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries Â- healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.

Further Reading: What is FinTech?

Get a free copy of the Zacks research report on Ventas (VTR)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with's FREE daily email newsletter.